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Abstract
Background: In the management of asthma, features of care important to patients may not be
fully appreciated. This study quantifies the importance of different features of asthma management
from the patient perspective. This may assist in the development of personalised management
strategies.
Methods: We used the technique of discrete choice experiment (DCE). Patients over 18 years of
age with asthma, prescribed and taking medicine at step 3 of the UK guidelines were recruited from
15 general (family) practices in three areas of the UK. 147 evaluable questionnaires were returned
from a total of 348 sent out. The outcome measures were the relative importance to patients of
features of asthma management and the impact of changes in asthma management, as measured by
utility shift between the features tested.
Results: The largest shift in mean utility values was recorded in "number of inhalers" and "use of
inhaled steroid". Use of a personal asthma action plan was ranked next highest.
Conclusion: This study suggests that adults with moderate or severe asthma would trade some
improvements in symptom relief in favour of, for example, simpler treatment regimens that use as
few inhalers as possible and a lower dose of inhaled steroid.
Background
Patient "self management" or "self care," a concept that
enables patients to take a guided but ultimately personal
involvement in the management of their condition, is an
increasingly debated element of healthcare provision. It is
particularly relevant as the prevalence of long term condi-
tions increases and growing numbers of people desire a
more active role in their own care with a less paternalistic
approach from healthcare professionals [1]. Effective self
care has the potential to improve clinical outcomes and
reduce use of healthcare resources [1,2].
Asthma is an ideal condition in which to strive for
improved patient outcomes by optimising self manage-
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ment because it typically fluctuates over time, with symp-
toms and exacerbations that can potentially be minimised
with self monitoring and appropriate adjustment of treat-
ment [3,4]. Self management of asthma is currently sub-
optimal in many patients, with around 50% self
managing in ways that differ from recommended guid-
ance [5-7].
A key step in improving the self management of asthma is
to understand what patients consider important. Patient
education programmes designed to improve self care have
traditionally centred on what health professionals con-
sider to be important, for example, lung function, asthma
symptoms and bronchodilator use in asthma [8]. Previ-
ous research has shown that patients have different per-
ceptions of asthma compared to health professionals and
that education tailored to meet patients' perceptions is
more likely to change behaviour [7].
This study was designed to quantify the relative impor-
tance of features of the management of asthma from the
patients' perspective. We used discrete choice experiment
methodology, a type of conjoint analysis that has been
shown to be a rigorous survey technique for eliciting pref-
erences [9]. It is increasingly being used to identify patient
and public preferences for health care [10,11]. The tech-
nique allows respondents to choose their preferred option
between hypothetical scenarios designed to reflect the dif-
ferent attributes that real world decisions would contain,
and to make trade offs between these attributes to reveal
their preferences. This technique of revealing preference
through choice is a truer representation of real life deci-
sion-making and as such may be a better tool for estab-
lishing preference than data based on the ranking or
rating of individual components of asthma management
[12].
A clearer understanding of such preferences may help
healthcare professionals tailor an acceptable personalised
management of asthma with their patient and conse-
quently move nearer to controlled asthma [13].
A brief description of discrete choice experiment, a work-
ing example and a glossary of technical terms and jargon
are provided at Additional file 1.
Methods
We carried out a discrete choice experiment (DCE) to
determine the characteristics of long term asthma man-
agement that patients consider most important, requiring
them to make choices between hypothetical scenarios and
thus reveal their preferences.
Ethical approval was granted by Warwickshire Local
Research Ethics Committee on behalf of COREC UK refer-
ence number 04/Q2803/66.
The study population and questionnaire
To ensure a reasonable spread both geographically and
socio-economically, 15 general practices from three geo-
graphical areas of the United Kingdom (UK) (West of
Scotland, Norfolk, Gloucestershire), with a total popula-
tion of 116 000 patients, took part in the study. Nursing
staff at each practice identified all patients on treatment
step 3 or above in the British Asthma Guidelines (regular
use of inhaled steroid and other therapies)[14] who had
received a prescription for asthma in the last 12 months,
were over 18 years of age, and were believed to be able to
understand and complete the questionnaire used in the
study. The patients identified were included in a practice
held "asthma register". The diagnostic criteria for inclu-
sion in this register were likely to be variable. In many
cases, a diagnosis of asthma will have been given and
accepted without formal, objective evidence of asthma.
This scenario is consistent with standard UK practice.
Patients on UK asthma guideline treatment step 3 or
above were chosen because their asthma management, by
definition, is more complex than those at treatment steps
1 and 2.
A sample was selected by allocating each patient a unique
identification number and then by the use of a random
number generator computer program. The number
selected from each practice varied according to total eligi-
ble patient numbers, with a maximum of 30 patients per
practice. A total of 348 questionnaires were mailed. A tra-
ditional power calculation is not appropriate in calculat-
ing a sample size for a DCE, where rules of thumb and
experience drive the sample size decision. The accepted
rule of thumb for our experimental design (nine tasks and
two alternatives per task per respondent and no more
than three levels in any one attribute) is that the sample
size should be in excess of 83 [15].
The questionnaire presented respondents with nine pairs
of choices (see Figure 1 and Additional file 2) – the dis-
crete choice experiment. Socio-demographic information
was also collected.
Establishing the attributes and their levels for the discrete 
choice experiment
The key attributes for this discrete choice experiment were
drawn from a previous study which included qualitative
interviews with more than 400 patients with asthma [16].
We chose six attributes highlighted by patients as being
the most important considerations in their long term
asthma management. These were: importance of gaining
relief of asthma symptoms from treatment; dose ofBMC Pulmonary Medicine 2007, 7:16 http://www.biomedcentral.com/1471-2466/7/16
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Example of question card Figure 1
Example of question card.BMC Pulmonary Medicine 2007, 7:16 http://www.biomedcentral.com/1471-2466/7/16
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inhaled steroid; the availability and content of a written
personalised asthma action plan; locus of crisis (exacerba-
tion) management; number of inhalers prescribed for
routine use; and response to a deterioration.
We chose and assigned what we considered to be plausi-
ble and realistic levels for the six attributes that represent
scenarios commonly found in asthma management.
Table 1 lists the levels chosen for each of the attributes.
A design program used in the statistical software SAS [17]
was used. This software produces a manageable number
of combinations of attributes and their respective levels
(or scenarios) to develop a survey questionnaire, balanc-
ing the statistical requirements with the need to avoid
overburdening the respondent with work. A total of nine
pairs of choices were produced. For each pair of scenarios,
respondents were asked to indicate the one they would
most prefer when considering how their asthma should
be managed (see Figure 1).
Data analysis
Using the techniques described in Additional file 3, the
overall relative importances of attributes at both individ-
ual and aggregate (group) levels, and shifts in utility val-
ues between each level within each attribute were
calculated (see additional files).
Results
A total of 148 questionnaires were returned after one
reminder, of which one was returned blank, from a total
of 348 sent out, giving a useable response rate of 43%.
Table 2 summarises the sociodemographic characteristics
of the study population, while Table 3 compares basic
characteristics of responders with non-responders.
Table 1: Attributes and levels included in the study and constraints applied prior to analysis
Attribute Levels Description Constraints
Symptom relief provided by 
your treatment  Completely
 Mostly
 A little
ORDINAL Completely
> Mostly
> A little
Inhaled steroid dose
 Always a low dose
 High dose when required but generally as little as possible
 High and regular steroid use
NOMINAL (with 
constraints)
Always low > Always high 
(no other assumptions 
made)
Use of a written 
personalised asthma action 
plan (PAAP)
 Full written instructions are provided by your doctor or 
nurse on how to recognise worsening asthma and how to alter 
your therapy yourself
 Brief written note is provided on how to take your 
medication
 No written instructions are provided
NOMINAL None
Asthma crisis management You are encouraged to:
 Manage an asthma crisis yourself whenever possible
 Attend your local GP in the event of an asthma crisis
 Attend hospital in the event of an asthma crisis
NOMINAL (with 
constraints)
GP>Hospital 
Yourself>Hospital (no 
assumption on Yourself v 
GP)
Number of different 
inhalers  A single inhaler is provided to you which contains all the 
inhaled medication you need for the management of your asthma
 No more than two inhalers are provided for the management 
of your asthma
 Three inhalers are provided to you for the management of 
your asthma
ORDINAL 1>at most 2>3
Controlling your asthma 
symptoms
You are encouraged to:
 Change your own therapy in response to changes in your 
symptoms without consulting a doctor or a nurse
 Speak to a doctor or nurse before making changes to 
treatment
NOMINAL None
¾
¾
¾
¾
¾
¾
¾
¾
¾
¾
¾
¾
¾
¾
¾
¾
¾BMC Pulmonary Medicine 2007, 7:16 http://www.biomedcentral.com/1471-2466/7/16
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Non-responders, by definition, did not consent to their
involvement in the study. Consequently, a more detailed
comparison of characteristics or features of responders
and non-responders was not possible.
The Relative Importance results are presented in Table 4.
The outputs shown throughout are the means of the
parameters calculated at the level of individual respond-
ents. The means at aggregate level demonstrating relative
importance were also calculated and are included for
comparison, displaying where a non-homogenous
response occurs. See Additional file 1.
Figure 2 shows the importance that respondents placed
on changes between different levels within-attributes. The
degree of importance is seen by changes in utility values
for levels within the attributes. All 11 successive within
attribute transitions were statistically significant (P <
0.05), with the single exception of changing the manage-
ment of an asthma crisis from 'yourself' to 'visiting a GP/
nurse'. Those changes with the highest relative negative
impact on respondents' views of their asthma manage-
ment were:
• changing from 'no more than 2' to '3' inhalers,
• change in steroid dose from 'low but high when needed'
to 'always high',
• being encouraged 'to visit a hospital for crisis manage-
ment' rather than being encouraged 'to manage yourself'
or 'attend the local GP surgery',
• symptom relief provided by current treatment changing
from 'completely' to 'mostly',
• changing from 1 to 2 inhalers.
Discussion
The study emphasises the importance of keeping treat-
ment regimens simple. The results showed that adults
with moderate or more severe asthma considered that a
simple treatment regimen was the most important consid-
eration in the long-term management of their condition,
rather than symptom control without compromise. For
example, two of the top five highest utility shifts between
levels related to the number of inhalers they needed to
use. Changing from 'no more than two' to 'three' inhalers
had the highest relative negative impact on respondents'
views of their asthma management. While noting the
caveats of the relative importance analysis, number of
inhalers was ranked the most important attribute of
asthma management at both the aggregate (29.3%) and
individual levels (21.9%), suggesting a reasonably
homogenous view.
This preference for simpler treatment and fewer inhalers
confirms in a more systematic and rigorous way prefer-
ences for "fewer drug treatments" and "just one inhaler"
reported in a previous pan-European study [7] and con-
firms the findings from patient interviews in our previous
study [16]. Asthma is only one part of people's lives and
treatments that may need to be taken for decades should
be offered in the simplest format. Willingness to pay from
the patients' perspective – another factor that may influ-
ence treatment preference – was not addressed in this
study; the cost of therapy to patients may be less impor-
tant in the UK than in other healthcare settings; it was not
rated highly as an issue in our qualitative study [16].
The factor that patients rated as being of next highest rel-
ative importance, and which had the second greatest util-
ity shift, was the dose of inhaled steroid. Scope for
lowering the steroid dose without loss of asthma control
has previously been described [18] and the addition of an
Table 3: Characteristics of responders compared to non-responders
Responder Non-responder
Number Mean (SD) or percentage Number Mean (SD) or percentage
Age 147 53.2 yrs (16.2) 201 45.2 yrs (15.9)
Female Gender 99 67% 129 64%
Table 2: Descriptive characteristics of respondents (n = 147)
Characteristics Mean (SD) or n (%)
Age (missing = 1) 53.2 (16.2)
Male gender 48 (32.7)
Asthma duration
< 12 months 0
1 to 4 years 14 (9.5)
5 to 10 years 33 (22.4)
More than 10 years 100 (68.0)
English is first spoken language (missing = 2) 143 (97.3)
Difficulty of questionnaire (missing = 2)
Very 4 (2.7)
Moderately 20 (13.8)
Slightly 29 (20.0)
Not 92 (63.4)BMC Pulmonary Medicine 2007, 7:16 http://www.biomedcentral.com/1471-2466/7/16
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inhaled long-acting beta agonist often permits better con-
trol and use of a lower dose of inhaled steroid [14].
Use of a personalised asthma action plan came next in
patients' ranking of relative importance of the attributes of
asthma management that they were asked about. A dis-
couragingly small number, only 12 (8%) of respondents,
indicated that they held a written personalised asthma
action plan – two centres each accounted for three of these
patients and a further six practices each had one patient
with a plan. This low number of patients with an action
plan is similar to that found in previous studies [19] and
is disappointing, especially because it has previously been
shown that even those without plans would feel comfort-
able adjusting therapy themselves [16]. Written asthma
action plans have been shown both to improve outcomes
[3] and to improve compliance with asthma therapy [20],
to be cost-effective [21] and are strongly recommended in
asthma guidelines [14]. It may be that lack of familiarity
with the nature and benefits of using a personalised plan,
by both medical professionals and patients, may have
influenced these results and that a greater knowledge
would increase the popularity and use of what may be the
single most important non-therapeutic intervention in
asthma management. In this study, patients indicate a
desire for "brief" rather than "full" written instructions.
The next ranked factor was asthma crisis management.
The utility analysis showed that patients preferred to
avoid attending hospital even in the event of a crisis, a
theme we have reported in a different disease area and
population [22]. Knowledge of patient preference can
inform the clinician but will not, of course, be the only
factor to consider when deciding how and where to man-
age an acute exacerbation of asthma.
Perhaps surprisingly, controlling asthma symptoms was
ranked lower in patients' ranking of importance, and
relief of symptoms was considered least important in the
range of attributes tested. However, this does not mean
that people with asthma do not consider symptom relief
important, but indicates that respondents considered it
less important than the other attributes of asthma man-
agement they were asked to rank. This suggests that
patients were prepared, at least to some extent, to trade off
elements of efficacy for what they perceived to be other
benefits, such as lower doses of inhaled steroids.
Both 'asthma crisis management' and 'controlling your
asthma symptoms' had higher relative importance statis-
tics when determined by the individual level method than
by the aggregate level method. This means that there was
a division of opinion within respondents as to which level
in each of these two attributes was the most desirable.
There was some variation between respondents in the
extent to which they wanted to manage their own asthma
symptoms. Nearly two-thirds put a higher utility value on
being encouraged to 'change your own therapy' than
'speak to a doctor or nurse before making changes to treat-
ment' in the attribute of controlling asthma symptoms.
This indicates a split between patients wanting a collabo-
rative/active role in making changes to their asthma ther-
apy and those wanting a more passive role, at a similar
level to that reported previously [23].
One of the greatest strengths of this study is the use of dis-
crete choice experiment methodology, which is a rigorous
method of eliciting preferences. Previous studies have
demonstrated that respondents tend to behave in an inter-
nally valid and consistent manner when answering DCE
questions [24]. The study explored patients' preferences
between only the attributes and levels that were offered,
but these had been identified as being important from
patients interviewed in a previous study [16]. The major-
ity of the respondents found the questionnaire easy to
complete, although it is possible that the type of question-
naire and the task, which is likely to have been unfamiliar
to recipients, influenced the overall response rate.
Another possible limitation to the study is that the major-
ity of respondents were female (65%) and aged over 55
years (48%). However, this is similar to previous studies
exploring adult asthma patients' attitudes to their treat-
ment [9,23]. Responders were generally older (mean age
55 years) than non-responders (mean age 45 years) (P <
0.01), but there was no statistically significant difference
Table 4: Relative Importance (RI) of Attribute Ranges Tested
Attribute Individual Level RI Aggregate Level RI
Number of Different Inhalers 21.9% 29.3%
Inhaled Steroid Dose 20.3% 21.1%
Use of a Written PAAP 17.0% 12.3%
Asthma Crisis Management 15.2% 15.0%
Controlling Your Asthma Symptoms 14.4% 6.1%
Symptom Relief Provided by Your Treatment 11.3% 16.3%BMC Pulmonary Medicine 2007, 7:16 http://www.biomedcentral.com/1471-2466/7/16
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Mean utility values Figure 2
Mean utility values.
Use of a Written Personalised  Asthma Action Plan
-0.53
-0.06
0.59
-2.00
-1.50
-1.00
-0.50
0.00
0.50
1.00
1.50
Full  No written 
instructions 
Brief
Controlling Your Asthma Symptoms
-0.28
0.28
-2.00
-1.50
-1.00
-0.50
0.00
0.50
1.00
1.50
Speak to doctor/nurse Change your own 
therapy
Symptom Relief Provided By Your Treatment
-0.65
-0.18
0.84
-2.00
-1.50
-1.00
-0.50
0.00
0.50
1.00
1.50
A little Mostly Completely
Asthma Crisis Management
-0.88
0.39 0.49
-2.00
-1.50
-1.00
-0.50
0.00
0.50
1.00
1.50
Hospital Yourself GP
Number of Different Inhalers
-1.48
0.28
1.19
-2.00
-1.50
-1.00
-0.50
0.00
0.50
1.00
1.50
3 inhalers at most 2
inhalers
1 inhaler
Inhaled Steroid Dose
-1.14
0.36
0.78
-2.00
-1.50
-1.00
-0.50
0.00
0.50
1.00
1.50
Always high High when
required
Always LowBMC Pulmonary Medicine 2007, 7:16 http://www.biomedcentral.com/1471-2466/7/16
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in gender between respondents and non-respondents (P =
0.3%).
Conclusion
Taking a flexible, patient-centred approach to asthma
management means focusing on issues that patients con-
sider important. Our study indicates that this means mak-
ing treatment as simple as possible, with as few
medications and inhalers as can achieve symptom control
– ideally fewer than three, or even two, inhalers. It also
means using the lowest dose of inhaled steroid that can
effectively control asthma and avoiding hospitals for
emergency care, as well as minimising asthma symptoms.
There is clearly room for improvement in increasing the
number of patients receiving personalised asthma man-
agement plans, which should improve outcomes by
increasing compliance.
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